Each year, millions of people turn to diet pills to lose weight. As of 2022, about 15 percent of U.S. adults reported using a weight-loss supplement at some point in their lives. One popular ...

WASHINGTON — Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's new national priority voucher, suggesting it is a strong ...

An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers. The results are published ...

This article was reviewed by Julia Switzer, MD, FACOG. If you’re entering perimenopause or menopause, you’ve probably heard about hormone replacement therapy (HRT) — and you might be wondering about ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) currently available for the treatment of obesity are administered as a peptide-based subcutaneous injection, but oral (non-peptide) versions would ...

GLP-1 medications have been a life-changing tool to help people manage their blood sugar and lose weight. But the most popular forms of these medications have a big drawback: you have to inject ...

Ozempic Insulin box and injection pen or insulin cartridge pen for diabetes patients from Novo Nordisk. Blurred pharmacy background. Copenhagen, Denmark - January 29, 2024. A semaglutide pill is ...

A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight, with nearly one in five losing 20% or more. Unlike ...

Houston plant to make inputs for orforglipron, other advanced therapies CEO David Ricks says new plant to be major hub for orforglipron, with some production at new Indiana site Houston plant to ...

A pill form of the weight loss drug Wegovy was as effective as injections for people with obesity in a clinical trial, the drug's manufacturer said. Novo Nordisk said in its news release that ...

Novo Nordisk's experimental daily Wegovy pill helped patients lose about as much weight as its weekly injection, according to data from a late-stage trial. The pill has already been sent to U.S.